A novel domestic or foreign LMOs created through modern biotechnology under Article 2 (Definition) of the LMO Act

Draft partial amendment of the Transboundary Movement, etc. of Living Modified Organisms Act (32 page(s), in Korean)

1.    Through the introduction of the Preliminary Review System, low-risk LMOs in which foreign gene has not been introduced to the final product shall be exempted from risk review and approval on the import, production and contained use.

2.    Under the current law, LMOs (including animals, plants, and microorganisms) that have introduced drug-resistant genes must obtain the approval when they are imported and developed. In the amendment, the scope of approval has been reduced from living organisms to living microorganisms.

3.    The provision on the establishment and operation of confined field trial areas was created and the confined field trial areas shall be separately managed from research facilities to unify the management system.